News
-
Oxygen-permeable skeletons breathe life into implanted cell therapies
A hybrid encapsulation system for engineered cells enhances their ability to secrete therapeutics long-term.
-
Dan elected to National Academy of Inventors
Dan Anderson is elected to the National Academy of Inventors in recognition of inventions that have made a tangible impact on society.
-
Dan elected to National Academy of Medicine
Dan Anderson along with four other MIT faculty are honored for outstanding contributions to medical research.
-
An implantable device could enable injection-free control of diabetes
The device contains encapsulated cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy.
-
Enhancing immunogenicity of LNPs by adjuvanting ionizable lipid and mRNA
The Anderson Lab has engineered key vaccine components to boost immune response without a separate adjuvant.
-
Dan wins 2023 Exner Medal
Cheers to Dan Anderson, 2023 Wilhelm Exner Medal laureate! The ceremony and the public Exner Lectures are being held May 22-24 in Vienna, Austria.
-
Sanofi + Anderson Lab collaboration
Sanofi will provide $25 million in support of the Anderson Lab’s efforts to develop new delivery technology for mRNA.
-
Nanoparticles for pulmonary mRNA delivery and genome editing
The Anderson Lab’s new inhalable lipid nanoparticles deliver mRNA to the lung.
-
Orna Tx + Merck collaboration
Orna Therapeutics, co-founded by Dan Anderson to engineer circular RNA therapies, announced a collaboration with Merck.
Goodwin Fund
Over the years, the Goodwin Fund has generously enabled our students to attend research conferences.